1. Hauser WA. Incidence and prevalence. In: Engel JJ, Pedley TA (eds.). Epilepsy: A Comprehensive Textbook, Vol. 1. Lippincott-Raven, New York, 1997, pp. 47-57.

2. Engel JJ, Pedley TA. Introduction: what is epilepsy? In: Engel JJ, Pedley TA (eds.). Epilepsy: A Comprehensive Textbook, Vol. 1. Lipponcott-Raven, New York, 1997, pp. 1-10.

3. Baumann RJ. Classification and population studies of epilepsy. In: Anderson VE, Hauser WA, Penry JK, Sing CF (eds.). Genetic Basis of the Epilepsies. Raven, New York, 1982, pp. 11-20.

4. Wolf P. Historical aspects: the concept of idiopathy. In: Malafosse A, Genton P, Hirsch E, Marescaux C, Broglin D, Bernasconi R (eds.). Idiopathic Generalized Epilepsies: Clinical, Experimental, and Genetic Aspects. John Libbey, London, 1994, pp. 3-6.

5. Berkovic SF, Scheffer IE. Epilepsies with single gene inheritance. Brain Dev 1997;19:13-18.

6. Todorova MT, Burwell TJ, Seyfried TN. Environmental risk factors for multifactorial epilepsy in EL mice. Epilepsia 1999;40:1697-1707.

7. Browne TR, Holmes GL. Epilepsy. N Engl J Med 2001;344:1145-1151.

8. Porter RJ, Meldrum BS, Macdonald RL, et al. Antiepileptic drugs. In: Engel JJ, Pedley TA (eds.). Epilepsy: A Comprehensive Textbook, Vol. 2. Lippincott-Raven, New York, 1997, pp. 1379-1670.

9. Wheless JW, Baumgartner J, Ghanbari C. Vagus nerve stimulation and the ketogenic diet. Neurol Clin 2001;19:371-407.

10. Mattson RH. Monotherapy trials: endpoints. Epilepsy Res 2001;45:109-117; discussion, 119, 121-122.

11. Greene AE, Todorova MM, Seyfried TN. Perspectives on the metabolic management of epilepsy through dietary reduction of glucose and elevation of ketone bodies. J Neurochem 2003;86:529-537.

12. Eadie MJ, Bladin PF. A Disease Once Sacred: A History of the Medical Understanding of Epilepsy. John Libby, Eastleigh, UK, 2001, p. 248.

13. Clarke DD, Sokoloff L. Circulation and energy metabolism of the brain. In: Siegel GJ, Agranoff BW, Albers RW, Fisher SK, Uhler MD (eds.). Basic Neurochemistry: Molecular, Cellular and Medical Aspects. Lippincott-Raven, New York, 1999, pp. 637-669.

14. Owen OE, Morgan AP, Kemp HG, Sullivan JM, Herrera MG, Cahill GF, Jr. Brain metabolism during fasting. J Clin Invest 1967;46:1589-1595.

15. Cahill GF, Herrera MG, Morgan AP, et al. Hormone-fuel interrelationships during fasting. J Clin Invest 1966;45:1751-1769.

16. Lennox WG. Epilepsy and Related Disorders, Vol. 1. Little, Brown, Boston, 1960, p. 1168.

17. Freeman JM, Freeman JB, Kelly MT. The Ketogenic Diet: A Treatment for Epilepsy, 3rd ed. Demos, New York, 2000, p. 236.

18. Perkins P. The Gospel of Mark. In: Keck (ed.). The Interpreter's Bible, Vol. VIII: General Articles on the New Testament; The Gospel of Matthew; The Gospel of Mark. Abingdon, Nashville, TN, 1994, pp. 509-773.

19. Lennox WG, Cobb S. Studies in epilepsy: VIII. The clinical effect of fasting. Arch Neurol Psychiat 1928;20:771-779.

20. Bhagavan NV. Medical Biochemistry. Harcourt, New York, 2002, p. 1016.

21. Peterman MG. The ketogenic diet. J Am Med Assoc 1928;90:1427-1429.

22. Peterman MG. The ketogenic diet in epilepsy. J Am Med Assoc 1925;84:1979-1983.

23. Wilder R. The effects of ketonemia on the course of epilepsy. Mayo Clin Proc 1921;2:307-308.

24. Nordli DR Jr, De Vivo DC. The ketogenic diet revisited: back to the future. Epilepsia 1997;38:743-749.

25. Sirven J, Whedon B, Caplan D, et al. The ketogenic diet for intractable epilepsy in adults: preliminary results. Epilepsia 1999;40:1721-1726.

26. Vining EPG. Ketogenic diet. In: Engel JJ, Pedley TA (eds.). Epilepsy: A Comprehensive Textbook, Vol. 2. Lippincott-Raven, New York, 1997, pp. 1339-1344.

27. Todorova M, Tandon P, Madore RA, Stafstrom CE, Seyfried TN. Ketogenic diet inhibits epileptogen-esis in EL mice: a genetic model for idiopathic epilepsy. Epilepsia 2000;41:933-940.

28. Bough KJ, Matthews PJ, Eagles DA. A ketogenic diet has different effects upon seizures induced by maximal electroshock and by pentylenetetrazol infusion. Epilepsy Res 2000;38:105-114.

29. DeVivo DC, Leckie MP, Ferrendelli JS, McDougal DB Jr. Chronic ketosis and cerebral metabolism. Ann Neurol 1978;3:331-337.

30. Schwartzkroin PA. Mechanisms underlying the anti-epileptic efficacy of the ketogenic diet. Epilepsy Res 1999;37:171-180.

31. Harney JP, Madara J, I'Anson H. Effects of acute inhibition of fatty acid oxidation on latency to seizure and concentrations of beta hydroxybutyrate in plasma of rats maintained on calorie restriction and/or the ketogenic diet. Epilepsy Res 2002;49:239-246.

32. Rho JM, Anderson GD, Donevan SD, White HS. Acetoacetate, acetone, and dibenzylamine (a contaminant in l-(+)-beta-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo. Epilepsia 2002;43:358-361.

33. Appleton DB, DeVivo DC. An animal model for the ketogenic diet. Epilepsia 1974;15:211-227.

34. Nakazawa M, Kodama S, Matsuo T. Effects of ketogenic diet on electroconvulsive threshold and brain contents of adenosine nucleotides. Brain Dev 1983;5:375-380.

35. Bough KJ, Valiyil R, Han FT, Eagles DA. Seizure resistance is dependent upon age and calorie restriction in rats fed a ketogenic diet. Epilepsy Res 1999;35:21-28.

36. Rho JM, Kim DW, Robbins CA, Anderson GD, Schwartzkroin PA. Age-dependent differences in flurothyl seizure sensitivity in mice treated with a ketogenic diet. Epilepsy Res 1999;37:233-240.

37. Nehlig A, Pereira de Vasconcelos A. Glucose and ketone body utilization by the brain of neonatal rats. Prog Neurobiol 1993;40:163-221.

38. Al-Mudallal AS, Levin BE, Lust WD, Harik SI. Effects of unbalanced diets on cerebral glucose metabolism in the adult rat. Neurology 1995;45:2261-2265.

39. DeVivo DC, Pagliara AS, Prensky AL. Ketotic hypoglycemia and the ketogenic diet. Neurology 1973;23:640-649.

40. Likhodii SS, Musa K, Mendonca A, Dell C, Burnham WM, Cunnane SC. Dietary fat, ketosis, and seizure resistance in rats on the ketogenic diet. Epilepsia 2000;41:1400-1410.

41. Greene AE, Todorova MT, McGowan R, Seyfried TN. Caloric restriction inhibits seizure susceptibility in epileptic EL mice by reducing blood glucose. Epilepsia 2001;42:1371-1378.

42. Mattson MP, Duan W, Lee J, Guo Z. Suppression of brain aging and neurodegenerative disorders by dietary restriction and environmental enrichment: molecular mechanisms. Mech Ageing Dev 2001;122:757-778.

43. Weindruch R, Walford RL. The Retardation of Aging and Disease by Dietary Restriction. Charles C Thomas, Springfield, IL, 1988, p. 436.

44. Mukherjee P, El-Abbadi MM, Kasperzyk JL, Ranes MK, Seyfried TN. Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model. Br J Cancer 2002;86:1615-1621.

45. Mattson MP, Chan SL, Duan W. Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior. Physiol Rev 2002;82:637-672.

46. Eckles-Smith K, Clayton D, Bickford P, Browning MD. Caloric restriction prevents age-related deficits in LTP and in NMDA receptor expression. Mol Brain Res 2000;78:154-162.

47. Duffy PH, Leakey JEA, Pipkin JL, Turturro A, Hart RW. The physiologic, neurologic, and behavioral effects of caloric restriction related to aging, disease, and environmental factors. Environ Res 1997;73:242-248.

48. Mukherjee P, Sotnikov AV, Mangian HJ, Zhou JR, Visek WJ, Clinton SK. Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression. J Natl Cancer Inst 1999;91:512-523.

49. Birt DF, Yaktine A, Duysen E. Glucocorticoid mediation of dietary energy restriction inhibition of mouse skin carcinogenesis. J Nutr 1999;129:571S-574S.

50. Veech RL, Chance B, Kashiwaya Y, Lardy HA, Cahill GF, Jr. Ketone bodies, potential therapeutic uses. IUBMB Life 2001;51:241-247.

51. Sato K, Kashiwaya Y, Keon CA, et al. Insulin, ketone bodies, and mitochondrial energy transduction. FASEB J 1995;9:651-658.

52. Seyfried TN, Poderycki MJ, Todorova MT. Genetics of the EL mouse: a multifactorial epilepsy model. In: Genton P, Berkovic S, Hirsch E, Marescaux C (eds.). Genetics of Focal Epilepsies. John Libbey, London, 1999, pp. 229-238.

53. Uchibori M, Saito K, Yokoyama S, et al. Foci identification of spike discharges in the EEGs of sleeping EL mice based on the electric field model and wavelet decomposition of multimonopolar derivations. J Neurosci Methods 2002;117:51-63.

54. Ishida N, Kasamo K, Nakamoto Y, Suzuki J. Epileptic seizure of EL mouse initiates at the parietal cortex: depth EEG observation in freely moving condition using buffer amplifier. Brain Res 1993;608:52-57.

55. Suzuki J, Kasamo K, Ishida N, Murashima YL. Initiation, propagation and generalization of paroxysmal discharges in an epileptic mutant animal. Jpn J Psychol Neurol 1991;45:271-274.

56. Suzuki J, Nakamoto Y. Seizure patterns and electroencephalograms of EL mouse. Electroencephalogr Clin Neurophysiol 1977;43:299-311.

57. Suzuki J. Paroxysmal discharges in the electroencephalogram of the EL mouse. Experientia 1976;32:336-338.

58. Sato H. The development of EEG background activities in EL mouse. Folia Psychiatr Neurol Jpn 1985;39:581-587.

59. Nakano H, Saito K, Suzuki K. Chronic implantation technique for monopolar EEG monitoring of epileptic seizures in mice. Brain Res Bull 1994;35:261-268.

60. Lambert JD, Fueta Y, Roepstorff A, Andreasen M. Analysis of the kinetics of synaptic inhibition points to a reduction in GABA release in area CA1 of the genetically epileptic mouse, EL. Epilepsy Res 1996;26:15-23.

61. Fueta Y, Kawano H, Ono T, Mita T, Fukata K, Ohno K. Regional differences in hippocampal excitability manifested by paired-pulse stimulation of genetically epileptic EL mice. Brain Res 1998;779:324-328.

62. Ingram EM, Wiseman JW, Tessler S, Emson PC. Reduction of glial glutamate transporters in the parietal cortex and hippocampus of the EL mouse. J Neurochem 2001;79:564-575.

63. Flavin HJ, Seyfried TN. Enhanced aspartate release related to epilepsy in (EL) mice. J Neurochem 1994;63:592-595.

64. Flavin HJ, Wieraszko A, Seyfried TN. Enhanced aspartate release from hippocampal slices of epileptic (EL) mice. J Neurochem 1991;56:1007-1011.

65. Murashima YL, Kasamo K, Suzuki J. Developmental abnormalities of GABAergic system are involved in the formation of epileptogenesis in the EL. Neurosciences 1992;18 (Suppl 2):63-73.

66. Hiramatsu M, Edamatsu R, Suzuki S, Shimada M, Mori A. Regional excitatory and inhibitory amino acid levels in epileptic EL mouse brain. Neurochem Res 1990;15:821-825.

67. Brigande JV, Wieraszko A, Albert MD, Balkema GW, Seyfried TN. Biochemical correlates of epilepsy in the EL mouse: analysis of glial fibrillary acidic protein and gangliosides. J Neurochem 1992;58:752-760.

68. Drage MG, Holmes GL, Seyfried TN. Hippocampal neurons and glia in epileptic EL mice. J Neuro-cytol 2003; in press.

69. Poderycki MJ, Simoes JM, Todorova M, Neumann PE, Seyfried TN. Environmental influences on epilepsy gene mapping in EL mice. J Neurogenet 1998;12:67-86.

70. Keenan KP, Ballam GC, Soper KA, Laroque P, Coleman JB, Dixit R. Diet, caloric restriction, and the rodent bioassay. Toxicol Sci 1999;52:24-34.

71. Pugh TD, Klopp RG, Weindruch R. Controlling caloric consumption: protocols for rodents and rhesus monkeys. Neurobiol Aging 1999;20:157-165.

72. Lang TA, Secic M. How to Report Statistics in Medicine. American College Physicians, Philadelphia, 1997.

73. Schwechter EM, Veliskova J, Velisek L. Correlation between extracellular glucose and seizure susceptibility in adult rats. Ann Neurol 2003;53:91-101.

74. Mantis JG, Centeno N, Todorova MT, McGowan R, Seyfried TN. Metabolic control of epilepsy in adult EL mice with the ketogenic diet and caloric restriction. Epilepsia 2003; abstract, in press.

75. Nehlig A. Age-dependent pathways of brain energy metabolism: the suckling rat, a natural model of the ketogenic diet. Epilepsy Res 1999;37:211-221.

76. Krebs HA, Williamson DH, Bates MW, Page MA, Hawkins RA. The role of ketone bodies in caloric homeostasis. Adv Enzyme Reg 1971;9:387-409.

77. Freeman JM, Vining EP. Seizures decrease rapidly after fasting: preliminary studies of the ketogenic diet. Arch Pediatr Adolesc Med 1999;153:946-949.

78. Livingston S. Dietary treatment of epilepsy. In: Livingston S (ed.). Comprehensive management of epilepsy in infancy, childhood and adolescence. Charles C Thomas, Springfield, IL, 1972, pp. 378-405.

79. Sacks DB. Carbohydrates. In: Burtis CA, Ashwood ER (eds.). Tietz Fundamentals of Clinical Chemistry. Saunders, New York, 2001, pp. 427-461.

80. McIlwain H. Cerebral energy metabolism and membrane phenomena. In: Jasper HH, Ward AAJ, Pope A (eds.). Basic Mechanisms of the Epilepsies. Little, Brown, Boston, 1969, pp. 83-103.

81. Meldrum B, Chapman A. Epileptic seizures and epilepsy. In: Siegel GJ, Agranoff BW, Albers RW, Fisher SK, Uhler MD (eds.). Basic Neurochemistry: Molecular, Cellular and Medical Aspects. Lippincott-Raven, New York, 1999, pp. 755-768.

82. Li X, Yokono K, Okada Y. Phosphofructokinase, a glycolytic regulatory enzyme has a crucial role for maintenance of synaptic activity in guinea pig hippocampal slices. Neurosci Lett 2000;294:81-84.

83. Meric P, Barrere B, Peres M, et al. Effects of kainate-induced seizures on cerebral metabolism: a combined 1H and 31P NMR study in rat. Brain Res 1994;638:53-60.

84. Ting YL, Degani H. Energetics and glucose metabolism in hippocampal slices during depolarization: 31P and 13C NMR studies. Brain Res 1993;610:16-23.

85. Folbergrova J. Cerebral energy state of neonatal rats during seizures induced by homocysteine. Physiol Res 1993;42:155-160.

86. Ackermann RF, Lear JL. Glycolysis-induced discordance between glucose metabolic rates measured with radiolabeled fluorodeoxyglucose and glucose. J Cereb Blood Flow Metab 1989;9:774-785.

87. During MJ, Fried I, Leone P, Katz A, Spencer DD. Direct measurement of extracellular lactate in the human hippocampus during spontaneous seizures. J Neurochem 1994;62:2356-2361.

88. Cornford EM, Shamsa K, Zeitzer JM, et al. Regional analyses of CNS microdialysate glucose and lactate in seizure patients. Epilepsia 2002;43:1360-1371.

89. Dhahbi JM, Mote PL, Wingo J, et al. Caloric restriction alters the feeding response of key metabolic enzyme genes. Mech Ageing Dev 2001;122:1033-1048.

90. Lee CK, Weindruch R, Prolla TA. Gene-expression profile of the ageing brain in mice. Nat Genet 2000;25:294-297.

91. Kashiwaya Y, Takeshima T, Mori N, Nakashima K, Clarke K, Veech RL. D-beta-Hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. Proc Natl Acad Sci U S A 2000;97:5440-5444.

92. Pellerin L, Pellegri G, Martin JL, Magistretti PJ. Expression of monocarboxylate transporter mRNAs in mouse brain: support for a distinct role of lactate as an energy substrate for the neonatal vs adult brain. Proc Natl Acad Sci USA 1998;95:3990-3995.

93. Koehler-Stec EM, Simpson IA, Vannucci SJ, Landschulz KT, Landschulz WH. Monocarboxylate transporter expression in mouse brain. Am J Physiol 1998;275:E516-E524.

94. Leino RL, Gerhart DZ, Duelli R, Enerson BE, Drewes LR. Diet-induced ketosis increases monocarboxylate transporter (MCT1) levels in rat brain. Neurochem Int 2001;38:519-527.

95. McIlwain H, Bachelard H. Biochemistry and the Central Nervous System. Churchill Livingstone, New York, 1985, p. 660.

96. Fredericks M, Ramsey RB. 3-Oxo acid coenzyme A transferase activity in brain and tumors of the nervous system. J Neurochem 1978;31:1529-1531.

97. Kashiwaya Y, Sato K, Tsuchiya N, et al. Control of glucose utilization in working perfused rat heart. J Biol Chem 1994;269:25502-25514.

98. Erecinska M, Nelson D, Daikhin Y, Yudkoff M. Regulation of GABA level in rat brain synaptosomes: fluxes through enzymes of the GABA shunt and effects of glutamate, calcium, and ketone bodies. J Neurochem 1996;67:2325-2334.

99. Daikhin Y, Yudkoff M. Ketone bodies and brain glutamate and GABA metabolism. Dev Neurosci 1998;20:358-364.

100. Yudkoff M, Daikhin Y, Nissim I, Lazarow A, Nissim I. Ketogenic diet, amino acid metabolism, and seizure control. J Neurosci Res 2001;66:931-940.

101. Kaur G, Kaur K. Effect of acute starvation on monoamine oxidase and Na+,K+-ATPase activity in rat brain. Mol Chem Neuropathol 1990;13:175-183.

102. Silver IA, Erecinska M. Energetic demands of the Na+/K+ ATPase in mammalian astrocytes. Glia 1997;21:35-45.

103. Pellerin L, Magistretti PJ. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci U S A 1994;91:10625-10629.

104. Petroff OA, Errante LD, Rothman DL, Kim JH, Spencer DD. Glutamate-glutamine cycling in the epileptic human hippocampus. Epilepsia 2002;43:703-710.

105. Redies C, Hoffer LJ, Beil C, et al. Generalized decrease in brain glucose metabolism during fasting in humans studied by PET. Am J Physiol 1989;256:E805-E810.

106. Kadekaro M, Ito M, Gross PM. Local cerebral glucose utilization is increased in acutely adrenalec-tomized rats. Neuroendocrinology 1988;47:329-334.

107. Haymond MW, Howard C, Ben-Galim E, DeVivo DC. Effects of ketosis on glucose flux in children and adults. Am J Physiol 1983;245:E373-E378.

108. Spanaki MV, Siegel H, Kopylev L, et al. The effect of vigabatrin (gamma-vinyl GABA) on cerebral blood flow and metabolism. Neurology 1999;53:1518-1522.

109. Leiderman DB, Balish M, Bromfield EB, Theodore WH. Effect of valproate on human cerebral glucose metabolism. Epilepsia 1991;32:417-422.

110. Theodore WH, Bairamian D, Newmark ME, et al. Effect of phenytoin on human cerebral glucose metabolism. J Cereb Blood Flow Metab 1986;6:315-320.

111. Theodore WH, DiChiro G, Margolin R, Fishbein D, Porter RJ, Brooks RA. Barbiturates reduce human cerebral glucose metabolism. Neurology 1986;36:60-64.

112. Theodore WH, Bromfield E, Onorati L. The effect of carbamazepine on cerebral glucose metabolism. Ann Neurol 1989;25:516-520.

113. Gadde KM, Franciscy DM, Wagner HR, 2nd, Krishnan KR. Zonisamide for weight loss in obese adults: a randomized controlled trial. JAMA 2003;289:1820-1825.

114. Brown RO, Orr CD, Hanna DL, Williams JE, Dickerson RN. Topiramate and weight loss in patients with neurodevelopmental disabilities. Pharmacotherapy 2002;22:831-835.

115. Ormrod D, McClellan K. Topiramate: a review of its use in childhood epilepsy. Paediatr Drugs 2001;3:293-319.

116. Hesdorffer DC, Stables JP, Hauser WA, Annegers JF, Cascino G. Are certain diuretics also anticonvulsants? Ann Neurol 2001;50:458-462.

117. Dimitriadis G, Tegos C, Golfinopoulou L, Roboti C, Raptis S. Furosemide-induced hyperglycaemia: the implication of glycolytic kinases. Horm Metab Res 1993;25:557-559.

118. Roslin M, Kurian M. The use of electrical stimulation of the vagus nerve to treat morbid obesity. Epilepsy Behav 2001;2:S11-S16.

119. Szekely M. The vagus nerve in thermoregulation and energy metabolism. Auton Neurosci 2000;85:26-38.

Turbo Metabolism

Turbo Metabolism

Forget Silly Diets-They Don't Work. Weight loss has got to be the most frustrating experience for many people, young and old alike. Eating foods that are just horrible, denying yourself foods you truly love and enjoy. Exercising, even though you absolutely hate exercising, and end up stiff as a board with no results.

Get My Free Ebook

Post a comment